Cytomegalovirus

The AST Handbook of Transplant Infections

Volumn , Issue , 2011, Pages 34-41

  Razonable, Raymund R ^a   Humar, Atul ^b  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Alternative strategy and agent(s); Antiviral prophylaxis being preferred, valganciclovir; Interpretation of pediatric CMV serology in donors and recipients <18 months; Prevention of cytomegalovirus (CMV) disease in solid organ transplant (SOT) recipients; Primary (preferred) strategy and agent; Specific pathogens cytomegalovirus; Treatment of acute rejection (if ALG is used); Treatment of CMV infection and disease in SOT recipients; Type of transplant modifying circumstance

Indexed keywords

EID: 84955363037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444397949.ch14     Document Type: Chapter

References (6)

1. Am J Transplantation 2009; 9(s4): S78.
2. Am J Transplantation 2010; 10(5):1228.
3. New Engl J Med 1999; 340(19): 1462.
4. Transplantation 2005; 80(2): 157.
5. Ann Int Med 2010: 152(12): 761.
6. Transplantation 2010; 89(7): 779.